Position in AMGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$363,568
-$156,114 QoQ
Shares Held
1,004
-32.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,408
of 3,139 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SEVEN MILE ADVISORY holds $5,274,200 across 10 Drug Manufacturers - General names. AMGN ranks #7 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,085 | $1,301,381 | |
| 2 | JNJ |
Johnson & Johnson
|
2,945 | $747,941 | |
| 3 | NVS |
Novartis AG
|
3,996 | $626,253 | |
| 4 | MRK |
Merck & Co., Inc.
|
4,571 | $587,373 | |
| 5 | ABBV |
AbbVie Inc.
|
1,941 | $488,433 | |
| 6 | AZN |
Astrazeneca PLC
|
2,129 | $403,700 | |
| 7 | AMGN |
Amgen Inc
This page
|
1,004 | $363,568 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,749 | $347,308 |
All Filings in AMGN
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $363,568 | 1,004 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $519,682 | 1,477 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $679,822 | 2,077 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $434,305 | 1,539 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $237,886 | 852 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $277,591 | 891 | Shares | Sole | 2025-05-13 | |
| 2024-09-30 | $305,777 | 949 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $266,207 | 852 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $210,112 | 739 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $208,238 | 723 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $210,439 | 783 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||